Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19

BACKGROUND: A randomized controlled trial involving a high-risk, unvaccinated population that was conducted before the Omicron variant emerged found that nirmatrelvir–ritonavir was effective in preventing progression to severe COVID-19. Our objective was to evaluate the effectiveness of nirmatrelvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Kevin L., Wang, Jun, Tadrous, Mina, Langford, Bradley J., Daneman, Nick, Leung, Valerie, Gomes, Tara, Friedman, Lindsay, Daley, Peter, Brown, Kevin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928441/
https://www.ncbi.nlm.nih.gov/pubmed/36781188
http://dx.doi.org/10.1503/cmaj.221608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928441/
https://www.ncbi.nlm.nih.gov/pubmed/36781188
http://dx.doi.org/10.1503/cmaj.221608

Ejemplares similares